Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib
Go back to Cogent Biosciences Announces FDA Breakthrough Therapy Designation for Bezuclastinib| COGENT (NASDAQ: COGT) | Delayed: 34.89 -0.06 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.95 | 52 Week High | $5.57 | |||
| Open | $34.56 | 52 Week Low | $2.90 | |||
| Day High | $35.20 | P/E | 158.59 | |||
| Day Low | $34.42 | EPS | $0.22 | |||
| Volume | 54,312 | |||||
